Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Third Quarter Trading Update

1 Nov 2017 07:00

RNS Number : 1767V
Zotefoams PLC
01 November 2017
 

Zotefoams plc

("Zotefoams" or the "Company" or "Group")

 

Trading Update

 

1st November 2017 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the third quarter ended 30 September 2017.

 

Zotefoams is pleased to report continued strong trading during the third quarter, maintaining the momentum of organic sales growth experienced in the first half of the year.

 

· Full year revenues expected to be ahead of market expectations

 

· Adjusted profit before tax and exceptional items for the year ending 31 December 2017 expected to be at the top end of the range of market expectations

 

· Group revenue 22% ahead for the third quarter against the comparative period

 

· Group revenue 24% ahead for the first nine months against the comparative period

 

In constant currency sales grew 16% in the third quarter following a 14% increase for the first six months of the year. The year-to-date growth has been delivered across all business units, with particularly strong growth in High-Performance Products, during the third quarter.

 

Management continues to invest in its strong portfolio of growth prospects and to manage the higher growth rates of early stage opportunities. The order book for the fourth quarter gives confidence that the Company will exceed market expectations for Group revenue and therefore, at current foreign exchange rates, the Board expects adjusted profit before tax and exceptional items for the year ending 31 December 2017 to be at the top end of the range of market expectations.

 

 

 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"We are delighted with the strong organic growth achieved across all business units during the third quarter of 2017. Our ambition is to establish ourselves as the world leader in cellular materials technology in our chosen markets. To achieve this ambition, we are investing significantly in new equipment and enhanced business capability. The Board is confident of another year of positive progress and about the long-term prospects for the business."

 

 

 

- Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

IFC Advisory

+44 (0) 203 053 8671

Graham Herring

Miles Nolan

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUARWRBBAROAA
Date   Source Headline
15th Apr 20257:00 amRNSIssue of Equity
11th Apr 20254:14 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Apr 20253:25 pmRNSHolding(s) in Company
2nd Apr 20254:37 pmRNSDirector Declaration
20th Mar 20253:16 pmRNSHolding(s) in Company
19th Mar 20251:52 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSPreliminary Results
17th Mar 20251:00 pmRNSResults Presentation on Investor Meet Company
12th Mar 20252:50 pmRNSNotification Of Transactions Of Directors/PDMRs
10th Mar 20257:00 amRNSStrategic Investment in Asia
4th Mar 20254:41 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSCFO Retirement
27th Feb 20253:58 pmRNSHolding(s) in Company
12th Feb 20251:35 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 202511:34 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSTrading Update & Notice of Capital Markets Day
15th Jan 202511:04 amRNSNotification Of Transactions Of Directors/PDMRs
24th Dec 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Dec 20247:00 amRNSUpdate on ReZorce
13th Dec 20243:41 pmRNSHolding(s) in Company
12th Dec 20249:47 amRNSNotification Of Transactions Of Directors/PDMRs
26th Nov 20244:21 pmRNSHolding(s) in Company
25th Nov 20245:51 pmRNSHolding(s) in Company
12th Nov 20242:27 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20247:00 amRNSTrading Update
14th Oct 202410:02 amRNSNotification Of Transactions Of Directors/PDMRs
8th Oct 20242:17 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Sep 20241:20 pmRNSNotification Of Transactions Of Directors/PDMRs
23rd Aug 202411:42 amRNSHolding(s) in Company
14th Aug 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
6th Aug 20247:00 amRNSInterim Results
12th Jul 20244:14 pmRNSNotification Of Transactions Of Directors/PDMRs
8th Jul 20247:00 amRNSNotice of Results and Investor Presentation
5th Jul 20241:14 pmRNSHolding(s) in Company
13th Jun 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
5th Jun 20243:08 pmRNSNotification Of Transactions Of Directors/PDMRs
31st May 20244:45 pmRNSHolding(s) in Company
30th May 20243:07 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
22nd May 20242:01 pmRNSResult of the 2024 Annual General Meeting
22nd May 20247:00 amRNSTrading Update and Group CEO Succession
15th May 202410:07 amRNSNotification Of Transactions Of Directors/PDMRs
15th May 20247:00 amRNSUpdate on ReZorce® & beverage carton Media Launch
10th May 20247:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
7th May 20247:00 amRNSZotefoams and Shincell Global Alliance
19th Apr 20247:00 amRNSExclusivity agreement with Design Blue Limited
19th Apr 20247:00 amRNS2023 Annual Report & Notice of 2024 AGM
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Mar 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.